ZYBT

Profile

Full Name

Zhengye Biotechnology Holding Limited

Ticker Symbol

ZYBT

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

China

IPO

January 7, 2025

Indexes

Not included

Website

http://www.jlzybio.com

Employees

278

Key Details

Price

$7.18(-14.89%)

Market cap

$338.80M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$29.92M(-22.78% YoY)

Annual EPS

$0.09(-36.07% YoY)

PE ratio

-

Next earnings date

May 19, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.18
    ZYBT price is $7.18

    30-Day Relative Volume

    1.51
    ZYBT 30-day relative volume is 1.51

    Price Performance

    Price Today change

    -14.89%
    ZYBT price is down -14.89% today

    Price YTD change

    -
    ZYBT price ytd change is unknown

    Price 1-year change

    -
    ZYBT price 1-year change is unknown

    Price 3-year change

    -
    ZYBT price 3-year change is unknown

    Price Range

    Price All-time high

    $14.30
    ZYBT price is currently -49.77% below its historical high of $14.30

    Price 3-year low

    $3.50
    ZYBT price is currently +105.23% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $338.80M
    ZYBT market capitalization is $338.80 million

    Market cap 3-year change

    -
    ZYBT market capitalization 3-year change is unknown

    Market cap All-time high

    $667.40M
    ZYBT market capitalization is currently -49.24% below its historical high of $667.40 million

    Market cap sector rank

    63.56%
    ZYBT market capitalization is higher than 63.56% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -
    ZYBT shares outstanding 1-year change is unknown

    Shares Outstanding 3-Year Change

    -
    ZYBT shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.56
    ZYBT beta is 1.56

    200-day SMA

    $5.93
    ZYBT price is currently +21.20% above its 200-day simple moving average

    50-day SMA

    $7.04
    ZYBT price is currently +2.10% above its 50-day simple moving average

    RSI

    48.23
    ZYBT 14-day relative strength index is 48.23

    Volume

    1.51
    ZYBT 30-day relative volume is 1.51

    ATR

    $2.83
    ZYBT average true range is $2.83

    10-day Historical Volatility

    352.94%
    ZYBT 10-day historical volatility is 352.94%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $29.92M
    ZYBT annual revenue is $29.92 million

    Revenue Analysts estimate

    -
    ZYBT annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -22.78%
    ZYBT annual revenue is down -22.78% year-on-year

    Revenue Sector rank

    38.96%
    ZYBT annual revenue is higher than 38.96% of companies in Healthcare sector

    EPS

    EPS

    $0.09
    ZYBT annual earnings per share is $0.09

    EPS Analysts estimate

    -
    ZYBT annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -36.07%
    ZYBT annual earnings per share is down -36.07% year-on-year

    EPS Sector rank

    83.37%
    ZYBT annual earnings per share is higher than 83.37% of companies in Healthcare sector

    Profit

    Gross profit

    $18.36M
    ZYBT annual gross profit is $18.36 million

    Gross margin

    61.35%
    ZYBT annual gross profit margin is 61.35%

    Operating profit

    $8.16M
    ZYBT annual operating income is $8.16 million

    Operating margin

    27.26%
    ZYBT annual operating profit margin is 27.26%

    Net income

    $4.45M
    ZYBT annual net profit is $4.45 million

    Net margin

    14.86%
    ZYBT annual net profit margin is 14.86%

    Expenses

    Total expenses

    $21.77M
    ZYBT annual total expenses is $21.77 million

    Operating expenses

    $10.20M
    ZYBT annual total operating expenses is $10.20 million

    Cost of goods sold

    $11.56M
    ZYBT annual cost of goods sold is $11.56 million

    Selling, general & administrative expenses

    $9.42M
    ZYBT annual SGA is $9.42 million

    Depreciation and amortization

    $3.38M
    ZYBT annual depreciation & amortization is $3.38 million

    Interest expense

    $625.30K
    ZYBT annual interest expense is $625.30 thousand

    Income tax

    $884.00K
    ZYBT annual income tax is $884.00 thousand

    EBIT & EBITDA

    EBIT

    $6.81M
    ZYBT annual earnings before interest & taxes is $6.81 million

    EBITDA

    $10.19M
    ZYBT annual EBITDA is $10.19 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $70.52M
    ZYBT annual total assets is $70.52 million

    Non current assets

    $41.52M
    ZYBT annual long term assets is $41.52 million

    Current assets

    $29.00M
    ZYBT annual total current assets is $29.00 million

    Cash and cash equivalents

    $2.13M
    ZYBT annual cash & cash equivalents is $2.13 million

    Accounts receivable

    $10.46M
    ZYBT annual accounts receivable is $10.46 million

    Inventory

    $8.22M
    ZYBT annual inventory is $8.22 million

    Liabilities

    Total liabilities

    $22.66M
    ZYBT annual total liabilities is $22.66 million

    Long term liabilities

    $1.46M
    ZYBT annual total long term liabilities is $1.46 million

    Current liabilities

    $21.19M
    ZYBT annual total current liabilities is $21.19 million

    Accounts payable

    $6.44M
    ZYBT annual accounts payable is $6.44 million

    Debt

    Total debt

    $12.68M
    ZYBT annual total debt is $12.68 million

    Total debt 1-year change

    +34.79%
    ZYBT annual total debt is up +34.79% year-on-year

    Long term debt

    $1.41M
    ZYBT annual long term debt is $1.41 million

    Short term debt

    $11.27M
    ZYBT annual short term debt is $11.27 million

    Equity & Capital

    Shareholders equity

    $38.49M
    ZYBT annual stockholders equity is $38.49 million

    Book value

    $38.49M
    ZYBT annual book value is $38.49 million

    Retained earnings

    $5.41M
    ZYBT annual retained earnings is $5.41 million

    Working capital

    $7.81M
    ZYBT annual working capital is $7.81 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $6.81M
    ZYBT annual cash flow from operations is $6.81 million

    Cash from operations 1-year change

    +163.95%
    ZYBT annual cash flow from operations is up +163.95% year-on-year

    Cash from investing

    -$1.66M
    ZYBT annual cash flow from investing activities is -$1.66 million

    Cash from investing 1-year change

    +59.12%
    ZYBT annual cash flow from investing activities is up +59.12% year-on-year

    Cash from financing

    -$2.68M
    ZYBT annual cash flow from financing activities is -$2.68 million

    Cash from financing 1-year change

    -233.95%
    ZYBT annual cash flow from financing activities is down -233.95% year-on-year

    CAPEX

    CAPEX

    $1.64M
    ZYBT annual capital expenditures is $1.64 million

    CAPEX 1-year change

    -59.69%
    ZYBT annual capital expenditures is down -59.69% year-on-year

    Free Cash Flow

    Free cash flow

    $5.17M
    ZYBT annual free cash flow is $5.17 million

    Free cash flow 1-year change

    +447.64%
    ZYBT annual free cash flow is up +447.64% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    61.35%
    ZYBT annual gross profit margin is 61.35%

    Operating margin

    27.26%
    ZYBT annual operating profit margin is 27.26%

    Net margin

    14.86%
    ZYBT annual net profit margin is 14.86%

    ROA & ROE

    ROA

    6.10%
    ZYBT annual return on assets is 6.10%

    ROE

    8.93%
    ZYBT annual return on equity is 8.93%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ZYBT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ZYBT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    8.74
    ZYBT price to book ratio is 8.74

    PB ratio Sector rank

    89.78%
    ZYBT price to book ratio is higher than 89.78% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ZYBT price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ZYBT price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $349.83M
    ZYBT enterprise value is $349.83 million

    Enterprise value Sector rank

    64.66%
    ZYBT enterprise value is higher than 64.66% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -
    ZYBT EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    ZYBT EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.37
    ZYBT annual current ratio is 1.37

    Quick ratio

    0.98
    ZYBT annual quick ratio is 0.98

    Leverage

    Debt to equity

    0.33
    ZYBT annual debt to equity ratio is 0.33

    Interest coverage ratio

    10.89
    ZYBT annual interest coverage ratio is 10.89

    Risk & Stability

    Piotroski F-Score

    -
    ZYBT piotroski f-score value is unknown

    Altman Z-Score

    9.95
    ZYBT altman z-score is 9.95

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with ZYBT included

    Stocks with high beta
    Best performing stocks last month
    Chinese stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    High Altman Z score stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Zhengye Biotechnology Holding Limited?
    • Does Zhengye Biotechnology Holding Limited pay dividends?
    • What sector is Zhengye Biotechnology Holding Limited in?
    • What industry is Zhengye Biotechnology Holding Limited in?
    • What country is Zhengye Biotechnology Holding Limited based in?
    • When did Zhengye Biotechnology Holding Limited go public?
    • Is Zhengye Biotechnology Holding Limited in the S&P 500?
    • Is Zhengye Biotechnology Holding Limited in the NASDAQ 100?
    • Is Zhengye Biotechnology Holding Limited in the Dow Jones?
    • When was Zhengye Biotechnology Holding Limited's last earnings report?
    • When does Zhengye Biotechnology Holding Limited report earnings?

    What is the ticker symbol for Zhengye Biotechnology Holding Limited?

    The ticker symbol for Zhengye Biotechnology Holding Limited is NASDAQ:ZYBT

    Does Zhengye Biotechnology Holding Limited pay dividends?

    No, Zhengye Biotechnology Holding Limited does not pay dividends

    What sector is Zhengye Biotechnology Holding Limited in?

    Zhengye Biotechnology Holding Limited is in the Healthcare sector

    What industry is Zhengye Biotechnology Holding Limited in?

    Zhengye Biotechnology Holding Limited is in the Drug Manufacturers - Specialty & Generic industry

    What country is Zhengye Biotechnology Holding Limited based in?

    Zhengye Biotechnology Holding Limited is headquartered in China

    When did Zhengye Biotechnology Holding Limited go public?

    Zhengye Biotechnology Holding Limited's initial public offering (IPO) was on January 7, 2025

    Is Zhengye Biotechnology Holding Limited in the S&P 500?

    No, Zhengye Biotechnology Holding Limited is not included in the S&P 500 index

    Is Zhengye Biotechnology Holding Limited in the NASDAQ 100?

    No, Zhengye Biotechnology Holding Limited is not included in the NASDAQ 100 index

    Is Zhengye Biotechnology Holding Limited in the Dow Jones?

    No, Zhengye Biotechnology Holding Limited is not included in the Dow Jones index

    When was Zhengye Biotechnology Holding Limited's last earnings report?

    Zhengye Biotechnology Holding Limited's most recent earnings report was on May 12, 2025

    When does Zhengye Biotechnology Holding Limited report earnings?

    The next expected earnings date for Zhengye Biotechnology Holding Limited is May 19, 2025
    On this page